683 Capital Management’s Immunomedics Inc IMMU Stock Holding History

683 Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-50,000	Closed	-$4.25M	–	235
2020 Q3	$4.25M	Hold	50,000	–	–	0.31%	58
2020 Q2	$1.77M	Buy	+50,000	New	+$1.46M	0.14%	83
2018 Q1	–	Sell	-80,000	Closed	-$1.29M	–	169
2017 Q4	$1.29M	Sell	80,000 -145,000	-64%	-$1.71M	0.11%	102
2017 Q3	$3.15M	Sell	225,000 -100,000	-31%	-$997K	0.33%	63
2017 Q2	$2.87M	Sell	325,000 -500,000	-61%	-$3.51M	0.42%	59
2017 Q1	$5.34M	Buy	825,000 +250,000	+43%	+$1.27M	0.83%	37
2016 Q4	$2.11M	Buy	+575,000	New	+$1.7M	0.15%	80

683 Capital Management's IMMU Position: Q4 2020 in Review

683 Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 50,000 shares — an estimated $4.25M sold.

683 Capital Management first reported a position in IMMU in Q4 2016 and held it in 7 quarters. The position peaked at $5.34M in Q1 2017. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

683 Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
683 Capital Management sold 50,000 Immunomedics Inc shares in Q4 2020, an estimated $4.25M.
683 Capital Management first reported a position in Immunomedics Inc in Q4 2016 and held it in 7 quarters.
683 Capital Management's Immunomedics Inc position peaked at $5.34M in Q1 2017.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on 683 Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.